EUR/USD has kicked off the week on the back foot amid US inflation concerns. Furthermore, worries about the virus' spread in Europe are weighing on the euro, Yohay Elam, an Analyst at FXStreet, reports.
EUR/USD pressured under 1.19
“At an inflection point – that is how Federal Reserve Chair Jerome Powell has described the economy, which is reopening rapidly and creating jobs amid America's successful vaccination campaign – which provides the dollar advantage over the euro. Around 35% of Americans have received at least one shot, while the figure in Europe is below 20%.”
“Tension is now mounting toward Tuesday's Consumer Price Index statistics. Economists expect annual inflation to rise in the coming months and uncertainty about its sustainability is what is driving the dollar.”
“Even if the old continent is making some headway against the virus and jabbing its population at a faster rate, vaccines may prove less effective than previously thought. A study in Israel has shown that Pfizer's immunizations provide less protection against the South African variant of the virus. Such worries may boost the safe-haven dollar.”
“Support awaits at 1.1860, which cushioned it late last week. It is followed by 1.1820, which is where the 100 and 200 SMAs converge.”
“Resistance is at the April high of 1.1925, followed by 1.1950 and 1.1990, lines that were last seen in March.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.